ESOXC-ER Efficacy and Safety of an Extended Release (ER) Formulation of Oxcarbazepine (Apydan Extent) in Epileptic Patients
Clinical trial NCT01086501 · COMPLETED
Trial details
- NCT number
- NCT01086501
- Sponsor
- Desitin Arzneimittel GmbH
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-02-01
- Primary completion
- 2011-07-01
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.